<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82793">
  <stage>Registered</stage>
  <submitdate>2/05/2008</submitdate>
  <approvaldate>14/07/2008</approvaldate>
  <actrnumber>ACTRN12608000325303</actrnumber>
  <trial_identification>
    <studytitle>Doxycycline in Lymphanioleiomyomatosis (LAM):  a randomised double blind placebo controlled crossover trial</studytitle>
    <scientifictitle>Doxycycline in Lymphangioleiomyomatosis:  a randomised double blind placebo controlled crossover trial to study the safety and efficacy of doxycycline on lung function, exercise capacity, quality of life indices and cyst size in patients with LAM</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Clinical Trial Network (CTN) No 2007/269</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lymphangioleiomyomatosis</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Doxycycline: 100mgs daily, oral for 6 months, washout period of 4 weeks between treatments</interventions>
    <comparator>Placebo:methylcellulose 1 capsule daily, 6 months</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Exercise capacity: 6 minute walk response</outcome>
      <timepoint>6 months, 1 year</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in quality of life and Visual Analogue Score (VAS) dyspnoea scores</outcome>
      <timepoint>6 months, 1 year</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Lung function: carbon monoxide diffusing capacity (DLCO), arterial blood gases, alveolar-arterial (A-a) gradient, total lung capacity (TLC), Residual volume (RV)/total lung capacity (TLC) 
Change in size of lung cysts as assessed by a new automated computerised method.</outcome>
      <timepoint>6months, 1year</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>exhaled nitric oxide, exhaled breath condensate biomarkers, electronic nose (eNOSE) measurements</outcome>
      <timepoint>1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC)</outcome>
      <timepoint>1 year</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>a.	Aged 18 or over
b.	Informed signed consent
c.	Diagnosis of pulmonary LAM as determined preferably by biopsy, or chest CT scan findings compatible with LAM. 
d.	Abnormal lung function i.e. compatible with LAM. There will be no FEV1 exclusion criterion</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>a.	Pregnancy or breast feeding
b.	Inadequate contraception
c.	Significant gastrointestinal disease such as to interfere with drug absorption, or predispose to severe reflux oesophagitis
d.	Uncontrolled systemic disease
e.	Significant renal impairment
f.	Use of an investigational drug within the last 30 days.
g.	Previous lung transplantation
h.	Inability to attend scheduled clinic visits
i.	Inability to give informed consent
j.	Inability to perform pulmonary function testing 
k.	Chylous ascites sufficient to affect diaphragmatic function
l.	Pleural effusion sufficient to blunt the costophrenic angle on a PA chest roentgenogram.
m.	Acute pneumothorax within the past 2 months 
n.	Documented allergy to study drugs</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients recruited from the clinical database of LAM patients across Australia and New Zealand. Allocation to intervention was concealed. Performed by central randomisation by phone /fax /computer</concealment>
    <sequence>Simple randomisation by using a randomization table created by a computer software program</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>Randomised double blind placebo controlled</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>10/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr.Deborah Yates</primarysponsorname>
    <primarysponsoraddress>Dept of Thoracic Medicine, Xavier 4 St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>LAM Fighting Fund, St.Vincents Hospital</fundingname>
      <fundingaddress>St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>LAM Australia</fundingname>
      <fundingaddress>PO Box 168 
Rozelle NSW 2039</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>St.Vincents Hospital</sponsorname>
      <sponsoraddress>390, Victoria Street, 
Darlinghurst NSW 2010</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>A/Prof Allan R Glanville</othercollaboratorname>
      <othercollaboratoraddress>Dept of Thoracic Medicine, Xavier 4
St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Judy Black</othercollaboratorname>
      <othercollaboratoraddress>University of Sydney
NSW</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St.Vincents Hospital HREC</ethicname>
      <ethicaddress>390, Victoria Street, 
Darlinghurst NSW 2010</ethicaddress>
      <ethicapprovaldate>17/02/2007</ethicapprovaldate>
      <hrec>H06/138</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr.Deborah Yates</name>
      <address>Dept of Thoracic Medicine, Xavier 4
St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</address>
      <phone>+61 2 83821111</phone>
      <fax>+61 2 83823084</fax>
      <email>deborahy88@hotmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr.Anu Krishnan</name>
      <address>Dept of Thoracic Medicine, Xavier 4
St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</address>
      <phone>+61 2 83821111</phone>
      <fax>+61 2 83823084</fax>
      <email>akrishnan@stvincents.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr.Anu Krishnan</name>
      <address>Dept of Thoracic Medicine, Xavier 4
St.Vincents Hospital
390, Victoria Street, Darlinghurst NSW 2010</address>
      <phone>+61 2 83821111</phone>
      <fax>+61 2 83823084</fax>
      <email>akrishnan@stvincents.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>